Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2.
COVID-19 severity
IgM and IgG levels
data visualisation
minimal immune signature
multivariate data analysis
patient similarity network
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 10 2022
31 10 2022
Historique:
received:
31
08
2022
revised:
26
10
2022
accepted:
26
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Analysing complex datasets while maintaining the interpretability and explainability of outcomes for clinicians and patients is challenging, not only in viral infections. These datasets often include a variety of heterogeneous clinical, demographic, laboratory, and personal data, and it is not a single factor but a combination of multiple factors that contribute to patient characterisation and host response. Therefore, multivariate approaches are needed to analyse these complex patient datasets, which are impossible to analyse with univariate comparisons (e.g., one immune cell subset versus one clinical factor). Using a SARS-CoV-2 infection as an example, we employed a patient similarity network (PSN) approach to assess the relationship between host immune factors and the clinical course of infection and performed visualisation and data interpretation. A PSN analysis of ~85 immunological (cellular and humoral) and ~70 clinical factors in 250 recruited patients with coronavirus disease (COVID-19) who were sampled four to eight weeks after a PCR-confirmed SARS-CoV-2 infection identified a minimal immune signature, as well as clinical and laboratory factors strongly associated with disease severity. Our study demonstrates the benefits of implementing multivariate network approaches to identify relevant factors and visualise their relationships in a SARS-CoV-2 infection, but the model is generally applicable to any complex dataset.
Identifiants
pubmed: 36366522
pii: v14112422
doi: 10.3390/v14112422
pmc: PMC9697085
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Microorganisms. 2021 Aug 05;9(8):
pubmed: 34442750
ACS Chem Neurosci. 2020 Jun 3;11(11):1555-1562
pubmed: 32379417
Med (N Y). 2021 Jun 11;2(6):720-735.e4
pubmed: 33821250
Am J Infect Control. 2021 Sep;49(9):1152-1157
pubmed: 33930516
Osteoarthritis Cartilage. 2022 Dec;30(12):1583-1592
pubmed: 36126821
Sci Rep. 2021 Jan 11;11(1):322
pubmed: 33431934
J Mol Biol. 2018 Sep 14;430(18 Pt A):2924-2938
pubmed: 29860027
Ann Am Thorac Soc. 2022 Sep;19(9):1446-1447
pubmed: 35486858
PLoS One. 2021 Jan 28;16(1):e0244855
pubmed: 33507994
Emerg Microbes Infect. 2022 Dec;11(1):902-913
pubmed: 35240947
Am J Med Sci. 2020 Oct;360(4):348-356
pubmed: 32709397
Leuk Res. 2019 Apr;79:60-68
pubmed: 30852300
Front Psychol. 2019 Feb 13;10:242
pubmed: 30814965
Mol Syst Biol. 2019 Mar 14;15(3):e8497
pubmed: 30872331
Front Immunol. 2022 Jun 10;13:886431
pubmed: 35757700
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Immunobiology. 2022 May;227(3):152216
pubmed: 35436751
Life Sci. 2021 Apr 1;270:119124
pubmed: 33508291
Br J Psychiatry. 1975 Mar;126:237-40
pubmed: 1125504
Int J Environ Res Public Health. 2021 Sep 01;18(17):
pubmed: 34501817
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Viruses. 2022 Aug 28;14(9):
pubmed: 36146713
Sci Rep. 2022 Sep 14;12(1):15425
pubmed: 36104347
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
J Biomed Inform. 2018 Jul;83:87-96
pubmed: 29864490
J Arthroplasty. 2020 Jun;35(6):1545-1557
pubmed: 32067896
Front Immunol. 2020 Dec 03;11:611004
pubmed: 33343585
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 33941622
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):289-298
pubmed: 31376255
Sci Immunol. 2020 Sep 28;5(51):
pubmed: 32989174